UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 27, 2010 (September 23, 2010)
LIFEPOINT HOSPITALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-51251
|
|
20-1538254 |
(State or Other Jurisdiction
|
|
(Commission
|
|
(IRS Employer |
of Incorporation)
|
|
File Number)
|
|
Identification No.) |
|
|
|
103 Powell Court, Suite 200 |
|
|
Brentwood, Tennessee
|
|
37027 |
(Address of principal executive offices)
|
|
(Zip Code) |
(615) 372-8500
(Registrants telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement
1. Indenture and Senior Notes due 2020
On
September 23, 2010 LifePoint Hospitals, Inc. (the
Company) issued $400,000,000 aggregate
principal amount of 6.625% senior notes due 2020 (the Notes), which mature on October 1, 2020,
pursuant to an indenture, dated September 23, 2010, between the Company, the Guarantors (as defined
therein) and Bank of New York Mellon Trust Company, N.A., as trustee (the Indenture). The Notes
are guaranteed by substantially
all of the subsidiaries of the Company that guarantee the Companys senior
secured credit facilities.
The
Company will pay interest on the Notes at a rate of 6.625% per annum, payable semi-annually in
arrears on April 1 and October 1 of each year, commencing April 1, 2011.
The Company may redeem the Notes, in whole or part, at any time prior to October 1, 2015 at a
price equal to 100% of the principal amount of the Notes redeemed plus an applicable makewhole
premium, plus accrued and unpaid interest, if any, to the date of redemption. The Company may
redeem the Notes, in whole or in part, at any time on or after October 1, 2015, at specified
redemption prices plus accrued and unpaid interest, if any, to the date of redemption. At any time
before October 1, 2013, the Company may redeem up to 35% of the aggregate principal amount of the
Notes issued under the indenture with the net cash proceeds of one or more qualified equity
offerings at a redemption price equal to 106.625% of the principal amount of the Notes to be
redeemed, plus accrued and unpaid interest; provided that: at least 65% of the aggregate principal
amount of the Notes remains outstanding immediately after the occurrence of such redemption; and
such redemption occurs within 180 days of the date of the closing of any such qualified equity
offering.
The Indenture contains covenants that limit the Companys ability and the ability of Companys
restricted subsidiaries to, among other things: incur additional indebtedness, pay dividends
or repurchase capital stock, make certain investments, create liens, enter into certain types of
transactions with our affiliates and sell assets or consolidate or merge with or into other
companies. These covenants are subject to a number of important limitations and exceptions. The
Indenture also provides for events of default, which, if any of them occurs, would permit or
require the principal, premium, if any, interest and any other monetary obligations on all the then
outstanding Notes to be due and payable immediately.
The foregoing summary is qualified in its entirety by reference to the Indenture, a copy of
which is filed as Exhibit 4.1 to this Form 8-K.
2. Registration Rights Agreement
On September 23, 2010, the Company and the Guarantors entered into a registration rights
agreement (the Registration Rights Agreement) with Barclays Capital Inc. as representative of the
several initial purchasers (the Initial Purchasers) in connection with the Notes, pursuant to the
Indenture (as described above).
The Company has agreed to use commercially reasonable efforts to register with the SEC
exchange notes having substantially identical terms as the Notes and will use commercially
reasonable efforts to have an exchange offer registration statement declared effective, and cause
such exchange offer to be completed no later than 360 calendar days after the original issue date
of the Notes. Under certain circumstances, the Company may be required
to file a shelf registration
statement with respect to the Notes.
If the Company fails to meet the conditions set forth in the Registration Rights Agreement, it
has agreed to pay additional interest to the holders of the affected Notes under certain
circumstances. Any references to interest herein shall include any additional interest due and
payable pursuant to the registration rights agreement.